Studying Patients with Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders

Cystic fibrosis is a disease that affects many parts of the body, particularly the lungs and pancreas. The main purpose of this study is to further understand the natural history, clinical presentation, and genetics of cystic fibrosis.

Official Title

Diagnosis and Treatment of Patients with Cystic Fibrosis and Other Disorders of the Respiratory System or Pancreas

Conditions

– Bronchiectasis- Cystic Fibrosis- Pancreatic Insufficiency

Study Type

Study Design

Further Details

This is an omnibus protocol for studying patients with cystic fibrosis and other familial pulmonary and pancreatic disorders. The main purpose of the study is to expand knowledge of the natural history, clinical manifestations (phenotypes) and the genetic variants (genotypes) of cystic fibrosis. A well-characterized population of patients with cystic fibrosis will be invited to provide appropriate specimens for laboratory research and to participate in clinical trials of therapeutic agents for cystic fibrosis.

Study Start

Eligibility & Criteria

Genders Eligible for Study: Both Criteria INCLUSION CRITERIAPatients and family members with known or suspected CF and related disorders of the respiratory tract or pancreas as defined by clinical presentation, sweat testing and/or genotyping.Willingness of patients, or guardian to give informed consent.EXCLUSION CRITERIAAge less than 4 years.Concomitant medical, psychiatric or other problems which might complicate interpretation of studies of CF, or for which we are unable to provide adequate care.

Total Enrolment

999

Contact Details

[1] National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), 9000 Rockville Pike, Bethesda, Maryland, 20892, United States; Recruiting